Castle Biosciences chief commercial officer Tobin W. Juvenal reports sale of $206,523.392 in common shares
CSTL•Chief Commercial Officer Tobin W. Juvenal sold 6,116 Castle Biosciences shares, reducing his direct holdings to 32,737 shares. The sales occurred on November 9 and 11, 2026, at $32.67 and $35.044 per share, respectively.
1. Share sales
Tobin W. Juvenal sold 6,116 shares of Castle Biosciences common stock, reducing his direct holdings to 32,737 shares. He sold 3,288 shares on November 9, 2026, at $32.67 per share, and 2,828 shares on November 11 at $35.044 per share.
